Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares
FLAC
FLAC was delisted on the 22nd of November, 2022.
50 hedge funds and large institutions have $95.9M invested in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 3 closing their positions.
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
33% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 6
2% more funds holding
Funds holding: 49 → 50 (+1)
2% more capital invested
Capital invested by funds: $93.7M → $95.9M (+$2.21M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCL
Glazer Capital LLC
New York
|
+$6.82M |
| 2 |
Millennium Management
New York
|
+$2.41M |
| 3 |
ECU
Eisler Capital (UK)
London,
United Kingdom
|
+$2.04M |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$1.19M |
| 5 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$414K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
DG Capital Management
New York
|
-$4.32M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$3.48M |
| 3 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
-$1.97M |
| 4 |
PI
PEAK6 Investments
Chicago,
Illinois
|
-$1.38M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$263K |
FLAC Hedge Fund Activity: Q2 2022 in Review
50 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) for Q2 2022, worth a combined $95.9M — up 2.4% from $93.7M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new FLAC positions and 3 closed out — a net gain of 1 holder — while 8 added to existing stakes and 6 trimmed.
The largest buyer was Glazer Capital LLC, adding an estimated $6.82M. The largest seller was DG Capital Management, exiting entirely with an estimated $4.32M sold.
- 50 institutional investors held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) as of Q2 2022, up from 49 in Q1 2022.
- Funds reported $95.9M of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares stock for Q2 2022, up 2.4% quarter-over-quarter.
- 4 funds opened new Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares positions in Q2 2022 and 3 closed out, a net change of +1 holder.
- The largest Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares buyer in Q2 2022 was Glazer Capital LLC, an estimated $6.82M added.
- The largest Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares seller in Q2 2022 was DG Capital Management, an estimated $4.32M sold.
Based on aggregated 13F filings for Q2 2022.